Abridge Raises $250M in Series D Funding Round and Introduces New AI Technology for Clinical Conversations

Abridge, a leading generative AI platform for clinical conversations, has completed a $250 million Series D investment round. This milestone coincides with the company surpassing 100 deployments within some of the largest and most complex health systems in the United States. Elad Gil and IVP co-led the Series D investment, with contributions from several notable firms, including Bessemer Venture Partners, California Health Care Foundation, CapitalG, and others.

The funding aims to drive further development of AI capabilities and support broader commercial growth. The company's recent recognition as Best in KLAS for the Ambient AI segment comes alongside the introduction of its new Contextual Reasoning Engine - an AI architecture designed to create more clinically useful and billable notes at the point of care. This innovative technology addresses challenges faced by healthcare systems in producing comprehensive, billable notes, ultimately enhancing administrative efficiencies and allowing healthcare professionals to concentrate more on patient care.

Dr. Shiv Rao, Abridge CEO and Founder, stressed the company's commitment to serving health system partners with this investment supporting their long-term goals and core research and development. Abridge is currently operational in over 100 diverse healthcare systems across the U.S., catering to clinicians in various specialties and care settings, and supporting multiple languages.

Founded in 2018, Abridge's enterprise-grade AI platform aims to transform medical conversations into clinically useful and billable documentation at the point of care, ultimately reducing administrative burden and clinician burnout while improving the patient experience. The company's purpose-built AI platform, supported by Linked Evidence, sets the standard for responsible AI deployment in health systems and has garnered industry recognition, including being awarded Best in KLAS for the Ambient AI segment and other prestigious accolades.